|
Market Closed -
Other stock markets
|
After hours 02:26:32 am | |||
| 92.22 USD | +1.84% |
|
92.04 | -0.19% |
| 04:53pm | TD Cowen Adjusts Price Target on CVS Health to $110 From $105 | MT |
| 07/05 | CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says | MT |
Chart calendar CVS Health Corporation
Upcoming events on CVS Health Corporation
| 15/05/2025 | Présentation aux Actionnaires / Analystes | 05:30 pm |
| 15/05/2025 | Annual General Meeting | 05:30 pm |
| 22/07/2025 | Ex-dividend date - 0.665 USD | 09:30 am |
| 31/07/2025 | Earnings presentation | 05:30 pm |
| 23/10/2025 | Ex-dividend date - 0.665 USD | 09:30 am |
| 29/10/2025 | Earnings presentation | 05:30 pm |
| 09/12/2025 | Analyst/Investor Day | 06:30 pm |
| 22/01/2026 | Ex-dividend date - 0.665 USD | 10:30 am |
| 10/02/2026 | Earnings presentation | 06:30 pm |
| 23/04/2026 | Ex-dividend date - 0.665 USD | 09:30 am |
| 06/05/2026 | Earnings presentation | 05:30 pm |
| 14/05/2026 | Annual General Meeting | Day |
| 14/05/2026 | Présentation aux Actionnaires / Analystes | 05:30 pm |
Past events on CVS Health Corporation
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 357 776 354 613 0.89% | 372 809 371 638 0.32% | 402 067 399 972 0.52% | 408 400 | 424 613 | 445 497 |
|
EBITDA Million USD | Released Forecast Spread | 19 995 19 955 0.2% | 14 548 14 295 1.77% | 17 073 17 211 -0.8% | 18 480 | 20 475 | 22 838 |
|
EBIT Million USD | Released Forecast Spread | 17 534 17 388 0.84% | 11 976 11 784 1.63% | 14 443 14 308 0.94% | 15 619 | 17 322 | 19 219 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 11 173 11 515 -2.97% | 6 148 4 992 23.16% | 2 136 1 733 23.29% | 10 348 | 12 156 | 13 416 |
|
Net income Million USD | Released Forecast Spread | 8 344 8 577 -2.71% | 4 614 4 045 14.06% | 1 768 -184 1062.02% | 7 855 | 9 155 | 10 202 |
|
EPS USD | Released Forecast Spread | 6,47 6,69 -3.34% | 3,66 3,04 20.31% | 1,39 -0,28 595.49% | 6,13 | 7,12 | 8,16 |
| Announcement Date | 07/02/24 | 12/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 95 428 92 688 2.96% | 97 710 96 884 0.85% | 94 588 93 561 1.1% | 98 915 94 594 4.57% | 102 871 98 835 4.08% | 105 693 103 575 2.05% | 100 426 95 019 5.69% | 99 521 | 103 101 | 105 659 | 103 270 | 104 148 | 107 961 | 110 838 | 109 553 |
|
EBITDA Million USD | Released Forecast Spread | 3 201 3 801 -15.79% | 3 372 2 922 15.4% | 5 234 4 289 22.03% | 4 485 3 864 16.07% | 4 093 3 774 8.46% | 3 261 3 087 5.65% | 5 823 5 097 14.25% | 4 583 | 4 277 | 3 728 | 6 227 | 5 082 | 4 707 | 4 075 | 6 976 |
|
EBIT Million USD | Released Forecast Spread | 2 547 3 337 -23.68% | 2 728 2 367 15.25% | 4 579 3 678 24.49% | 3 808 3 208 18.72% | 3 459 3 095 11.76% | 2 597 2 459 5.6% | 5 150 4 527 13.76% | 3 889 | 3 748 | 2 984 | 5 504 | 4 320 | 4 120 | 3 383 | 6 119 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 105 2 253 -95.34% | 2 126 648 228.2% | 2 617 2 023 29.38% | 1 647 1 892 -12.97% | -3 482 1 475 -336.15% | 1 354 929 45.67% | 3 938 3 298 19.4% | 2 676 | 2 418 | 1 749 | 3 889 | 2 681 | 2 607 | 1 841 | 4 873 |
|
Net income Million USD | Released Forecast Spread | 87,0 1 667 -94.78% | 1 644 556 195.94% | 1 779 1 590 11.89% | 1 021 1 372 -25.58% | -3 975 1 138 -449.37% | 2 943 693 324.71% | 2 943 2 449 20.19% | 1 996 | 1 928 | 1 266 | 2 985 | 2 374 | 2 180 | 1 620 | 3 647 |
|
EPS USD | Released Forecast Spread | 0,07 1,31 -94.66% | 1,30 0,47 178.36% | 1,41 1,28 10.53% | 0,80 1,06 -24.55% | -3,13 0,95 -430.11% | 2,30 0,65 254.93% | 2,30 1,93 19.47% | 1,54 | 1,51 | 0,97 | 2,32 | 1,84 | 1,69 | 1,26 | 2,85 |
| Announcement Date | 06/11/24 | 12/02/25 | 01/05/25 | 31/07/25 | 29/10/25 | 10/02/26 | 06/05/26 | - | - | - | - | - | - | - | - |
| 13/05/2025 |  | Earnings release - Q1 2025 | |
| 13/05/2025 | | Earnings presentation | 02:30 am |
| 13/05/2025 | | Ex-dividend date - 0.025 SGD | 09:30 am |
| 13/05/2025 | | Annual General Meeting | 06:30 pm |
| 14/05/2025 | | Présentation aux Actionnaires / Analystes | 07:30 pm |
| 14/05/2025 | | Annual General Meeting | 07:30 pm |
| 15/05/2025 | | Présentation aux Actionnaires / Analystes | 06:30 pm |
| 15/05/2025 | | Annual General Meeting | 06:30 pm |
| 15/05/2025 | | Annual General Meeting | Day |
| 15/05/2025 | | Annual General Meeting | 01:30 am |
Past sector events for CVS Health Corporation
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVS Stock
- Calendar CVS Health Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition